Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/30/2012CN101474228B Detection method of wild chrysanthemum dispensing granule
05/30/2012CN101474225B Ledebouriella root granule as well as preparation method and quality control method
05/30/2012CN101474224B Notopterygium root dispensing granule as well as preparation method and quality control method
05/30/2012CN101474223B Chinese angelica root dispensing granule as well as preparation method and quality control method
05/30/2012CN101474221B Detection method of glehnia root dispensing granule
05/30/2012CN101474219B Detection method of achyranthes bidentata dispensing granule
05/30/2012CN101455643B Dry suspension and preparation method thereof
05/30/2012CN101455628B Preparation method of gel composition for eyes
05/30/2012CN101433716B Composition for treating malignant solid tumors and preparation thereof and use
05/30/2012CN101411693B Oral dosage form for controlled drug release
05/30/2012CN101405320B Microparticles comprising a crosslinked polymer
05/30/2012CN101402675B Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides
05/30/2012CN101401909B Pill for treating arterialocclusive angitis
05/30/2012CN101401879B Pill for treating acne on face
05/30/2012CN101396423B Kudzu root dispensing granule and preparation method and quality control method thereof
05/30/2012CN101385798B Wind dispelling and pain relieving paste
05/30/2012CN101375968B Chinese medicinal composition as well as preparation method and application thereof
05/30/2012CN101342258B Hooked uncaria prescription particle, preparation method and quality control method thereof
05/30/2012CN101317819B Rotigotine flexible liposome and transdermal drug administration formulation for hydrophilic substance
05/30/2012CN101278977B Method for extracting main active components of mulberry leaf and application of its extract
05/30/2012CN101278937B Clear eye lotion containing latanoprost as effective ingredient
05/30/2012CN101274053B Detection method of capsules for curing waist pain
05/30/2012CN101259289B Methods and compositions for therapeutic use of RNA interference
05/30/2012CN101254282B Combination for curing cervical vertebra disease
05/30/2012CN101199565B Sanchi bud activity part and preparing method thereof
05/30/2012CN101185710B Powder agent medicine for treating chronic otitis media suppurative
05/30/2012CN101181227B Solid lipid nanometer particle in-situ gel rubber preparations of biological adherent cyclosporine A and preparation method thereof
05/30/2012CN101161262B A medicine for treating chronic renal failure and its preparing method
05/30/2012CN101157731B Preparation method for low agriculture remanet panax ginseng and American ginseng polysaccharide extractive
05/30/2012CN101112609B Fresh ginger formulation particles and method for preparing the same and quality control method thereof
05/30/2012CN101085072B Sustained-release tablet containing folium crataegi total flavone
05/30/2012CN101081224B Stable extended release oral dosage composition
05/30/2012CN101073598B Medicinal composition for treating cardiovascular and cerebrovascular disease and its preparation
05/30/2012CN101036764B Chinese medicine preparation for treating fastrointestinal disease and its preparation process
05/30/2012CN101035541B Neuroprotective effect of solubilized UDCA in focal ischemic model
05/30/2012CN101028353B Keeled cervical vertebrae medicine and its production
05/30/2012CN101005824B Oral care film
05/29/2012US8188308 Crystal of glutathione and process for production thereof
05/29/2012US8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
05/29/2012US8188275 hydrolase enzyme inhibors such as 2-(6-Chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
05/29/2012US8188107 T-614 is a cyclooxygenase-2 inhibitor; reduced plasma concentrations of an opioid analgesic, while still providing effective pain management; side effect reduction
05/29/2012US8188037 Microparticles comprising somatostatin analogues
05/29/2012US8187672 Residual solvent extraction method and microparticles produced thereby
05/29/2012US8187659 Solid medicament dosage form consumption aid
05/29/2012US8187640 Low viscosity liquid polymeric delivery system
05/29/2012US8187638 Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles
05/29/2012US8187637 Formulations decreasing particle exhalation
05/29/2012US8187636 Drug and a trap; retards the rate of release of the drug from the dosage form when the dosage form has been tampered with; opiods
05/29/2012US8187635 Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
05/29/2012US8187634 Process for the preparation of sevelamer hydrochloride and formulation thereof
05/29/2012US8187633 Layered core contains active ingredient layer, a swellable compressed layer, and an excipient layer that is insoluble in gastric fluids; outer film attached to swellable layer to form rupturing system that ruptures when intestine is reached; pharmacokinetics
05/29/2012US8187632 Sustained-release preparations of quinolone antibiotics
05/29/2012US8187631 Direct compression polymer tablet core
05/29/2012US8187630 Extended release oral dosage composition
05/29/2012US8187629 Non-lamellar compositions of DOPE and P80
05/29/2012US8187628 Dermal composition for controlling drug flux comprising two acrylic adhesive polymers having different functionalities and different solubility parameters
05/29/2012US8187625 Cross-linked gelatin composition comprising a wetting agent
05/29/2012US8187623 Medical copolymers
05/29/2012US8187621 Methods and compositions for treating post-myocardial infarction damage
05/29/2012US8187617 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments
05/29/2012US8187616 Method for silk fibroin gelation using sonication
05/29/2012US8187615 Non-aqueous compositions for oral delivery of insoluble bioactive agents
05/29/2012US8187590 Probiotic, lactic acid-producing bacteria and uses thereof
05/29/2012US8187583 Oil-in-water emulsions
05/29/2012US8187574 Repeated spray at specified ratio to produce massage effect on the skin; deodorants, sun blocks, cleansers, pharmaceuticals
05/29/2012US8187513 Natural rubber, chalk, a molecular sieve/medicament adduct, or silicone rubber, chalk and a molecular sieve/medicament adduct, extruded into a tubing immediately precured with 15 to 25% of the total radiation dose, cutting the tubing, sealing, sterilization
05/29/2012US8187255 Medical devices having nanoporous coatings for controlled therapeutic agent delivery
05/29/2012US8186506 Packaging system for transdermal drug delivery systems
05/29/2012CA2583876C A transmucosal veterinary composition comprising detomidine
05/29/2012CA2557910C Methods of reducing aggregation of il-1ra
05/29/2012CA2555114C Enteric coatings for orally ingestible substrates
05/29/2012CA2554751C Anti-inflammatory analgesic for external use
05/29/2012CA2542778C Transdermal drug delivery composition
05/29/2012CA2529561C Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
05/29/2012CA2520522C Cladribine formulations for improved oral and transmucosal delivery
05/29/2012CA2516667C Treatment using dantrolene
05/29/2012CA2512487C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
05/29/2012CA2502219C A process for producing an amorphous isomer of lansoprazole
05/29/2012CA2483282C Polymeric microemulsions
05/29/2012CA2483214C Wound dressings comprising hydrated hydrogels and enzymes
05/29/2012CA2482499C Aerosol containing a particulate active substance
05/29/2012CA2448218C Sustained release formulation
05/29/2012CA2446738C Abuse-resistant opioid dosage form
05/29/2012CA2368855C Differentiation of monocytes into functional dendritic cells
05/29/2012CA2321596C Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
05/24/2012WO2012068549A2 Therapeutic agent formulations for implanted devices
05/24/2012WO2012068535A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate
05/24/2012WO2012068531A2 Novel compositions and uses of anti-hypertension agents for cancer therapy
05/24/2012WO2012068516A2 Low dose cannabinoid medicaments
05/24/2012WO2012068476A2 Poly(vinyl benzoate) nanoparticles for molecular delivery
05/24/2012WO2012068270A2 Enteric-coated sodium metabisulfite livestock feed additive for vomitoxin detoxification
05/24/2012WO2012068179A1 Multifunctional biodegradable peg nanocarrier-based hydrogels for preventing hiv transmission
05/24/2012WO2012068076A2 Pharmaceutical formulations containing soluble drugs
05/24/2012WO2012067621A1 Preparation and use of combination enzyme and gastrointestinal modulator delivery systems
05/24/2012WO2012067491A2 Compositions comprising extracts obtained from oil palm based materials for providing anti -inflammatory effects and method of producing thereof
05/24/2012WO2012067138A1 Novel polymer derivative of cytidine metabolism antagonist
05/24/2012WO2012066896A1 Combined pharmaceutical preparation
05/24/2012WO2012066538A1 Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
05/24/2012WO2012066537A2 Compositions for transdermal delivery of active agents
05/24/2012WO2012066506A2 Method
1 ... 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 ... 2991